Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics and big genomic data: from lab to clinic and back again.

Human molecular genetics - 1 May 2018

Lavertu Adam, McInnes Greg, Daneshjou Roxana, Whirl-Carrillo Michelle, Klein Teri E, Altman Russ B

Abstract excerpt

The field of pharmacogenomics is an area of great potential for near-term human health impacts from the big genomic data revolution. Pharmacogenomics research momentum is building with numerous hypotheses currently being investigated through the integration of molecular profiles of different cell lines and large genomic data sets containing information on cellular and human responses to therapies. Additionally,...

Topics

Join the communities discussing this publication.

Berberine and alkaloids research
Computational Drug Discovery Methods
Genomics
Genotype
Pharmacogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Pharmacogenetics and Drug Metabolism

Pharmacogenomic Testing

Source

Open in PubMed Open full text

Identifiers

PMID: 29635477
DOI: 10.1093/hmg/ddy116
PMCID: PMC5946941

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics and big genomic data: from lab to clinic and back again.PMID 29635477Read ↗

Whole genome sequencing in pharmacogenomicsSemantic proximity Read ↗

Harnessing the Power of Electronic Health Records and Genomics for Drug Discovery.Semantic proximity Read ↗

Progress towards the integration of pharmacogenomics in practice.Semantic proximity Read ↗

Pharmacogenetics: Opportunities for the All of Us Research Program and Other Large Data Sets to Advance the FieldSemantic proximity Read ↗

The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug DevelopmentSemantic proximity Read ↗

Pharmacogenomics: Current State-of-the-ArtSemantic proximity Read ↗

Emerging strategies and applications of pharmacogenomics.Semantic proximity Read ↗

From pharmacogenetics to pharmaco-omics: Milestones and future directionsSemantic proximity Read ↗

Pharmacogenomics in the era of next generation sequencing – from byte to bedsideSemantic proximity Read ↗

Integrating large-scale genotype and phenotype data.Semantic proximity Read ↗

Genetic databases and their potential in pharmacogenomics.Semantic proximity Read ↗

The emerging role of electronic medical records in pharmacogenomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.